Physician profile

Michael D Hoang

General Practice (Dentist) · West Melbourne, FL

NPI 1952830580

$182.58

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$24.92
Education$24.04

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Orapharma, A Division of Bausch Health US, LLC $50.68 2019-2024 Arestin
Align Technology, INC. $42.36 2020-2021
Colgate Oral Pharmaceuticals, INC. $24.04 2024
Philips North America LLC $23.32 2021
American Medical & Dental Supplies,INC. $20.00 2021
Gc America INC. $11.41 2021
Voco America INC. $10.77 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael D Hoang

$182.58

in general payments reported 2019-2025

Years
2019-2024
Top company
Orapharma, A Division of Bausch Health US, LLC

https://glasscript.com/doctor/3101180/michael-d-hoang

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.